EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elevated levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 in multiple system atrophy: a marker of disease-associated microglial activation

Toshiki Maeda, Yasuaki Mizutani, Reiko Ohdake, Ryunosuke Nagao, Kazuya Kawabata, Sayuri Shima, Akihiro Ueda, Mizuki Ito, Hirohisa Watanabe

Journal of Neural Transmission · 2025

DOI: 10.1007/s00702-025-03022-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neural Transmission, 2025. Verfasst von Toshiki Maeda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. Hauptthemen laut MEDLINE: Multiple System Atrophy, Membrane Glycoproteins, Microglia, Receptors, Immunologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple system atrophy (MSA) is increasingly being recognized to be characterized by neuroinflammation, especially involving the activation of microglia. Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in cerebrospinal fluid (CSF) has been proposed as a biomarker of microglial activation; however, its role in MSA remains unclear. Levels of glycoprotein nonmetastatic melanoma protein B (GPNMB) and neurofilament light chain (NfL) may also indicate MSA-related neuroinflammatory and neurodegenerative processes. In this cross-sectional study, we analyzed CSF samples from 44 MSA patients, 46 Parkinson's disease patients, 34 patients with progressive supranuclear palsy or corticobasal syndrome, and 40 age- and sex-matched controls enrolled from a hospital-based registry. CSF sTREM2, GPNMB, and NfL levels were quantified using enzyme-linked immunosorbent assays. STREM2 levels were compared among groups. In the MSA group, we examined correlations between sTREM2 levels and clinical variables, including GPNMB and NfL. CSF sTREM2 levels were significantly higher in all disease groups compared with controls, with the highest levels observed in the MSA group. In the MSA group, sTREM2 level was not correlated with most clinical scores; however, individuals with elevated sTREM2 levels tended to have higher depression scores. Additionally, sTREM2 level correlated strongly with CSF GPNMB (r = 0.467, p = 0.001) and NfL (r = 0.408, p = 0.006). Multiple regression further identified GPNMB and age at examination as significant predictors of sTREM2 abundance. Our findings suggest that sTREM2 reflects microglial activation and its association with the neuroinflammatory and neurodegenerative processes of MSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple System AtrophyMembrane GlycoproteinsMicrogliaReceptors, ImmunologicHumansMaleFemaleMiddle AgedAgedCross-Sectional StudiesBiomarkersParkinson DiseaseNeurofilament ProteinsSupranuclear Palsy, Progressive

Stichwörter der Autor:innen

Cerebrospinal fluid (CSF)Glycoprotein nonmetastatic melanoma protein B (GPNMB)Microglial activationMultiple system atrophyNeurodegenerationNeurofilament light chain (NfL)NeuroinflammationSoluble triggering receptor expressed on myeloid cells 2 (sTREM2)

Substanzen

Membrane GlycoproteinsTREM2 protein, humanReceptors, ImmunologicBiomarkersneurofilament protein LGPNMB protein, humanNeurofilament Proteins

Autor:innen und Institutionen

  • Department of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
  • Department of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. hirohisa.watanabe@fujita-hu.ac.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Maeda, T., Mizutani, Y., Ohdake, R., Nagao, R., Kawabata, K., Shima, S., Ueda, A., Ito, M., & Watanabe, H. (2025). Elevated levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 in multiple system atrophy: a marker of disease-associated microglial activation. Journal of Neural Transmission. https://doi.org/10.1007/s00702-025-03022-x

Vancouver

Maeda T, Mizutani Y, Ohdake R, Nagao R, Kawabata K, Shima S, et al. Elevated levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 in multiple system atrophy: a marker of disease-associated microglial activation. Journal of Neural Transmission. 2025. doi:10.1007/s00702-025-03022-x

BibTeX
@article{Maeda2025,
  author = {Maeda, Toshiki and Mizutani, Yasuaki and Ohdake, Reiko and Nagao, Ryunosuke and Kawabata, Kazuya and Shima, Sayuri and Ueda, Akihiro and Ito, Mizuki and Watanabe, Hirohisa},
  title = {Elevated levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 in multiple system atrophy: a marker of disease-associated microglial activation},
  journal = {Journal of Neural Transmission},
  year = {2025},
  doi = {10.1007/s00702-025-03022-x}
}
Kostenlos starten →